Friday, October 11, 2024

U.S. Department of Justice Civil Division Press Releases Update

U.S. Department of Justice


You are subscribed to Civil Division Press Releases for U.S. Department of Justice. This information has recently been updated, and is now available.

10/10/2024 08:00 AM EDT

A federal court has prohibited two Dallas-area physicians from prescribing opioids and other controlled substances and imposed a total of $1.2 million in judgments against them in a case alleging the physicians violated the Controlled Substances Act (CSA), the Justice Department announced today.
10/10/2024 08:00 AM EDT

Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (collectively, Teva) have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). Teva, headquartered in Parsippany, New Jersey, is the largest generic drug manufacturer in the United States. The settlement amount was based on Teva's ability to pay.
10/10/2024 08:00 AM EDT

The Justice Department has filed a civil lawsuit against Paul Bakhoum, who was the Vice President for Operations for Ecosolargy Inc., a California Corporation that imported Chinese-manufactured solar panels into the United States. The lawsuit alleges that Mr. Bakhoum made false statements to customs officials and, as a result, avoided paying harmonized tariff schedule (HTS), antidumping and countervailing duties owed on the imported solar panels.
 

 

No comments:

Page List

Blog Archive

Search This Blog

DOD Featured Photos

Milton Preps New York Air National Guard members prepare sea...